Screening of Cushing's syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy

…, A Pia, R Rinaldi, B Allasino… - The Journal of …, 2012 - academic.oup.com
Context: Cushing's syndrome may remain unrecognized among patients referred for metabolic
syndrome; thus, a proactive screening has been suggested in certain patient populations …

Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitus

G Reimondo, A Pia, B Allasino, F Tassone… - Clinical …, 2007 - Wiley Online Library
Objective Recent studies have shown that a relatively high number of diabetic patients may
have unsuspected Cushing's syndrome (CS). The aim of the present study was to screen for …

Hyperhomocysteinemia in patients with Cushing's syndrome

M Terzolo, B Allasino, S Bosio, E Brusa… - The Journal of …, 2004 - academic.oup.com
We evaluated serum homocysteine concentrations and the C677T polymorphism of the
gene encoding for methylene tetrahydrofolate reductase, a key enzyme for homocysteine …

Secondary hypoadrenalism

G Reimondo, S Bovio, B Allasino, M Terzolo, A Angeli - Pituitary, 2008 - Springer
Secondary adrenal insufficiency (SAI) is a clinical disorder that results from hypothalamic or
hypophyseal damage or from prolonged administration of supraphysiological doses of …

Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome

G Reimondo, B Allasino, S Bovio… - European journal of …, 2005 - academic.oup.com
Objective It is presently unclear whether the accuracy of midnight serum cortisol (F24) in the
diagnosis of Cushing's syndrome (CS) may be replicated under usual conditions of clinical …

Practical treatment using mitotane for adrenocortical carcinoma

M Terzolo, B Zaggia, B Allasino… - Current Opinion in …, 2014 - journals.lww.com
Mitotane concentration of 14–20 mg/l should be reached and maintained during treatment
also in an adjunctive setting. In advanced adrenocortical carcinoma, a high-dose starting …

Laboratory differentiation of Cushing's syndrome

G Reimondo, A Pia, S Bovio, B Allasino, F Daffara… - Clinica Chimica …, 2008 - Elsevier
Cushing's syndrome (CS) is a complex of signs and symptoms due to chronic glucocorticoid
excess from a variety of causes. Although CS is considered a rare disease, recent studies …

Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal nonosteoporotic women in the early postmenopausal period

G Osella, M Ventura, A Ardito, B Allasino… - European journal of …, 2012 - academic.oup.com
Objective The aim of the study was to evaluate the relationship between cortisol secretion,
bone health, and bone loss in a cohort of normal women in the early postmenopausal period. …

[HTML][HTML] Early outpatient treatment of COVID-19: a retrospective analysis of 392 cases in Italy

…, V Vernocchi, S Martini, F Marino, B Allasino… - Journal of Clinical …, 2022 - mdpi.com
COVID-19 was declared a pandemic in March 2020. The knowledge of COVID-19
pathophysiology soon provided a strong rationale for the early use of both anti-inflammatory and …

Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile

A Dovio, B Allasino, E Palmas, M Ventura… - The Journal of …, 2007 - academic.oup.com
Context: Patients with Cushing’s syndrome (CS) have a mortality rate four times higher than
age- and sex-matched subjects, mainly due to cardiovascular events. Serum …